4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-24-002842
Options or other derivatives
- Interim CEO acquired 639,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Walker Neal Interim CEO | 2024-02-01 | Grant or award · Stock Option (Right to Buy) | +497,000 | 497,000 | D: show line 1 in the form | |||||
| Walker Neal Interim CEO | 2024-02-01 | Grant or award · Restricted Stock Units | +142,000 | 142,000 | D: show line 2 in the form |
Loading xslF345X05/doc4.xml…